Christianson Mark's Form 4/A amendment
AmendedNeuroone Medical Technologies Corp (NMTC) · filed Feb 4, 2022
- Accession no.
- 0001709738-22-000001
- Filed
- Feb 4, 2022
- Trade date
- Jun 23-24, 2021
- Filing delay
- 226 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Jun 25, 2021
This filing lists 2 non-derivative transactions. Open-market sales total $79.9K. It was filed 226 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Christianson MarkCIK 0001709738 | Officer (Business Development Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2021 | Common Stock | SSaleDisposed | −11,300 | $6.74F1 | −$76,162 | 351,769 | Direct | |
| Jun 24, 2021 | Common Stock | SSaleDisposed | −600 | $6.30 | −$3,780 | 351,169 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares of the issuer's common stock were sold in multiple transactions at prices ranging from $6.50 to $6.97, inclusive. The reporting person undertakes to provide the issuer, any securityholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares of common stock sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F2
This amendment is being filed to correct the number of shares beneficially owned by the reporting person following the reported transaction. The issuer effected a one-for-three reverse stock split of shares of its common stock on March 31, 2021, and the total number of shares held by the reporting person has been corrected to adjust for the split.